Compare SYK & IBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYK | IBN |
|---|---|---|
| Founded | 1941 | 1955 |
| Country | United States | India |
| Employees | N/A | 185266 |
| Industry | Medical/Dental Instruments | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0B | 110.0B |
| IPO Year | 1994 | N/A |
| Metric | SYK | IBN |
|---|---|---|
| Price | $331.89 | $26.09 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $429.42 | N/A |
| AVG Volume (30 Days) | 2.1M | ★ 6.0M |
| Earning Date | 04-30-2026 | 04-21-2026 |
| Dividend Yield | ★ 1.06% | 0.83% |
| EPS Growth | ★ 8.25 | N/A |
| EPS | ★ 8.40 | N/A |
| Revenue | ★ $25,116,000,000.00 | N/A |
| Revenue This Year | $9.86 | N/A |
| Revenue Next Year | $8.39 | $14.51 |
| P/E Ratio | $39.47 | ★ $18.86 |
| Revenue Growth | ★ 11.16 | N/A |
| 52 Week Low | $319.32 | $25.08 |
| 52 Week High | $404.87 | $34.57 |
| Indicator | SYK | IBN |
|---|---|---|
| Relative Strength Index (RSI) | 37.74 | 40.01 |
| Support Level | $328.23 | N/A |
| Resistance Level | $375.26 | $31.51 |
| Average True Range (ATR) | 7.99 | 0.50 |
| MACD | 0.19 | 0.06 |
| Stochastic Oscillator | 35.08 | 38.97 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.